Shengtao Xu Selected Research

Shengtao Xu Research Topics

Disease

35	Neoplasms (Cancer) 12/2023 - 06/2013
6	Liver Neoplasms (Liver Cancer) 04/2021 - 05/2017
4	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 06/2013
2	Carcinogenesis 04/2024 - 12/2023
2	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2020
2	Breast Neoplasms (Breast Cancer) 12/2022 - 12/2021
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
1	Inflammation (Inflammations) 05/2024
1	Prostatic Neoplasms (Prostate Cancer) 04/2024
1	Atherosclerosis 01/2024
1	Infections 01/2023
1	Hyperpigmentation 01/2023
1	Hypertrophy 06/2022
1	Cardiomegaly (Heart Hypertrophy) 06/2022
1	Amnesia (Dissociative Amnesia) 10/2021
1	Amyloid Plaque 01/2021
1	Cognitive Dysfunction 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Infarction (Infarctions) 08/2020
1	Myocardial Infarction 08/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2019
1	Pathologic Processes 05/2019
1	Hypercholesterolemia 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Hypoxia (Hypoxemia) 05/2017
1	Human Influenza (Influenza) 01/2017

Drug/Important Bio-Agent (IBA)

12	oridoninIBA 05/2024 - 06/2012
6	TubulinIBA 12/2023 - 09/2018
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2024 - 05/2019
4	EnzymesIBA 12/2022 - 01/2016
3	elemeneIBA 01/2024 - 07/2017
3	Donepezil (Aricept)FDA LinkGeneric 05/2022 - 01/2021
3	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2016
2	Proteolysis Targeting ChimeraIBA 01/2023 - 01/2021
2	enmeinIBA 10/2022 - 02/2018
2	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 11/2014
2	ProdrugsIBA 10/2022 - 05/2017
2	AcetylcholinesteraseIBA 05/2022 - 01/2021
1	InflammasomesIBA 05/2024
1	ErbB Receptors (EGF Receptor)IBA 04/2024
1	Neuropilin-1IBA 12/2023
1	dihydrochalconeIBA 01/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	protopanaxadiolIBA 01/2023
1	Mitochondrial RNAIBA 01/2023
1	isotianilIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 10/2022
1	Atrial Natriuretic Factor (ANF)IBA 06/2022
1	SulfonesIBA 05/2022
1	Neuroprotective AgentsIBA 05/2022
1	evodiamineIBA 12/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	PyrimidinonesIBA 10/2021
1	Scopolamine (Hyoscine)FDA Link 10/2021
1	GlyceraldehydeIBA 10/2021
1	Tacrine (Cognex)FDA Link 10/2021
1	tau Proteins (tau Protein)IBA 10/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	alectinibIBA 01/2021
1	Nitric Oxide DonorsIBA 10/2020
1	deguelinIBA 10/2020
1	leonurineIBA 08/2020
1	Carbon MonoxideIBA 02/2020
1	GasotransmittersIBA 02/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020
1	HAO472IBA 01/2020
1	IntegrinsIBA 01/2020
1	23-hydroxybetulinic acidIBA 11/2019
1	EstersIBA 06/2019
1	fosbretabulin (combretastatin A4)IBA 02/2019
1	oxidized low density lipoproteinIBA 01/2019
1	LDL CholesterolIBA 01/2019
1	SaltsIBA 01/2019
1	naftopidilIBA 01/2019
1	divinyl sulfoneIBA 09/2018
1	Colchicine FDA LinkGeneric 09/2018
1	Caspase 3 (Caspase-3)IBA 02/2018
1	DiterpenesIBA 02/2018
1	Cytochromes c (Cytochrome c)IBA 02/2018
1	palmatineIBA 05/2017
1	quinone (benzoquinone)IBA 05/2017
1	protoberberineIBA 05/2017
1	Oxidoreductases (Dehydrogenase)IBA 05/2017
1	NAD (NADH)IBA 05/2017
1	oseltamivir carboxylateIBA 01/2017
1	LactonesIBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2023 - 01/2016
1	Immunotherapy 12/2023
1	Intravenous Injections 01/2019
1	Drug Therapy (Chemotherapy) 07/2017